Partnering Opportunities In Cardio/Metabolics: “Everybody’s Looking And Nobody’s Got”

Representatives from J&J, GSK, Pfizer and Boehringer Ingelheim discuss their companies’ thinking in terms of cardiovascular/metabolic drug development and business development activity at the TAP conference.

More from R&D

More from Pink Sheet